nodes	percent_of_prediction	percent_of_DWPC	metapath
Diethylpropion—Vomiting—Mitomycin—urinary bladder cancer	0.00476	0.00476	CcSEcCtD
Diethylpropion—Arrhythmia—Thiotepa—urinary bladder cancer	0.00474	0.00474	CcSEcCtD
Diethylpropion—Rash—Mitomycin—urinary bladder cancer	0.00472	0.00472	CcSEcCtD
Diethylpropion—Dermatitis—Mitomycin—urinary bladder cancer	0.00472	0.00472	CcSEcCtD
Diethylpropion—Headache—Mitomycin—urinary bladder cancer	0.00469	0.00469	CcSEcCtD
Diethylpropion—Alopecia—Thiotepa—urinary bladder cancer	0.00469	0.00469	CcSEcCtD
Diethylpropion—Agranulocytosis—Gemcitabine—urinary bladder cancer	0.00464	0.00464	CcSEcCtD
Diethylpropion—Sweating increased—Etoposide—urinary bladder cancer	0.00464	0.00464	CcSEcCtD
Diethylpropion—Erythema—Thiotepa—urinary bladder cancer	0.00462	0.00462	CcSEcCtD
Diethylpropion—Agranulocytosis—Fluorouracil—urinary bladder cancer	0.00456	0.00456	CcSEcCtD
Diethylpropion—Tension—Thiotepa—urinary bladder cancer	0.00453	0.00453	CcSEcCtD
Diethylpropion—Dyskinesia—Epirubicin—urinary bladder cancer	0.00452	0.00452	CcSEcCtD
Diethylpropion—Pancytopenia—Etoposide—urinary bladder cancer	0.00452	0.00452	CcSEcCtD
Diethylpropion—Nervousness—Thiotepa—urinary bladder cancer	0.00448	0.00448	CcSEcCtD
Diethylpropion—Nausea—Mitomycin—urinary bladder cancer	0.00445	0.00445	CcSEcCtD
Diethylpropion—Vision blurred—Thiotepa—urinary bladder cancer	0.00435	0.00435	CcSEcCtD
Diethylpropion—Agitation—Thiotepa—urinary bladder cancer	0.00424	0.00424	CcSEcCtD
Diethylpropion—Dyskinesia—Doxorubicin—urinary bladder cancer	0.00419	0.00419	CcSEcCtD
Diethylpropion—Leukopenia—Thiotepa—urinary bladder cancer	0.00413	0.00413	CcSEcCtD
Diethylpropion—Ecchymosis—Methotrexate—urinary bladder cancer	0.00411	0.00411	CcSEcCtD
Diethylpropion—Urine output increased—Methotrexate—urinary bladder cancer	0.00411	0.00411	CcSEcCtD
Diethylpropion—Gynaecomastia—Methotrexate—urinary bladder cancer	0.00407	0.00407	CcSEcCtD
Diethylpropion—Convulsion—Thiotepa—urinary bladder cancer	0.004	0.004	CcSEcCtD
Diethylpropion—Arrhythmia—Gemcitabine—urinary bladder cancer	0.00399	0.00399	CcSEcCtD
Diethylpropion—Agranulocytosis—Etoposide—urinary bladder cancer	0.00396	0.00396	CcSEcCtD
Diethylpropion—Alopecia—Gemcitabine—urinary bladder cancer	0.00394	0.00394	CcSEcCtD
Diethylpropion—Myalgia—Thiotepa—urinary bladder cancer	0.00393	0.00393	CcSEcCtD
Diethylpropion—Arrhythmia—Fluorouracil—urinary bladder cancer	0.00392	0.00392	CcSEcCtD
Diethylpropion—Anxiety—Thiotepa—urinary bladder cancer	0.00392	0.00392	CcSEcCtD
Diethylpropion—Erythema—Gemcitabine—urinary bladder cancer	0.00388	0.00388	CcSEcCtD
Diethylpropion—Alopecia—Fluorouracil—urinary bladder cancer	0.00388	0.00388	CcSEcCtD
Diethylpropion—Ecchymosis—Epirubicin—urinary bladder cancer	0.00384	0.00384	CcSEcCtD
Diethylpropion—Erythema—Fluorouracil—urinary bladder cancer	0.00382	0.00382	CcSEcCtD
Diethylpropion—Polyuria—Methotrexate—urinary bladder cancer	0.00376	0.00376	CcSEcCtD
Diethylpropion—Arrhythmia—Cisplatin—urinary bladder cancer	0.00371	0.00371	CcSEcCtD
Diethylpropion—Tachycardia—Thiotepa—urinary bladder cancer	0.00368	0.00368	CcSEcCtD
Diethylpropion—Alopecia—Cisplatin—urinary bladder cancer	0.00367	0.00367	CcSEcCtD
Diethylpropion—Erythema—Cisplatin—urinary bladder cancer	0.00362	0.00362	CcSEcCtD
Diethylpropion—Ill-defined disorder—Gemcitabine—urinary bladder cancer	0.0036	0.0036	CcSEcCtD
Diethylpropion—Vision blurred—Fluorouracil—urinary bladder cancer	0.0036	0.0036	CcSEcCtD
Diethylpropion—Ecchymosis—Doxorubicin—urinary bladder cancer	0.00356	0.00356	CcSEcCtD
Diethylpropion—Malaise—Gemcitabine—urinary bladder cancer	0.0035	0.0035	CcSEcCtD
Diethylpropion—Leukopenia—Gemcitabine—urinary bladder cancer	0.00348	0.00348	CcSEcCtD
Diethylpropion—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.00343	0.00343	CcSEcCtD
Diethylpropion—Leukopenia—Fluorouracil—urinary bladder cancer	0.00342	0.00342	CcSEcCtD
Diethylpropion—Vision blurred—Cisplatin—urinary bladder cancer	0.00341	0.00341	CcSEcCtD
Diethylpropion—Tremor—Cisplatin—urinary bladder cancer	0.00339	0.00339	CcSEcCtD
Diethylpropion—Alopecia—Etoposide—urinary bladder cancer	0.00337	0.00337	CcSEcCtD
Diethylpropion—Cerebrovascular accident—Methotrexate—urinary bladder cancer	0.00337	0.00337	CcSEcCtD
Diethylpropion—Ill-defined disorder—Cisplatin—urinary bladder cancer	0.00336	0.00336	CcSEcCtD
Diethylpropion—Somnolence—Thiotepa—urinary bladder cancer	0.00335	0.00335	CcSEcCtD
Diethylpropion—Dyspepsia—Thiotepa—urinary bladder cancer	0.00332	0.00332	CcSEcCtD
Diethylpropion—Convulsion—Fluorouracil—urinary bladder cancer	0.00331	0.00331	CcSEcCtD
Diethylpropion—Chest pain—Gemcitabine—urinary bladder cancer	0.00331	0.00331	CcSEcCtD
Diethylpropion—Myalgia—Gemcitabine—urinary bladder cancer	0.00331	0.00331	CcSEcCtD
Diethylpropion—Discomfort—Gemcitabine—urinary bladder cancer	0.00327	0.00327	CcSEcCtD
Diethylpropion—Malaise—Cisplatin—urinary bladder cancer	0.00326	0.00326	CcSEcCtD
Diethylpropion—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.00325	0.00325	CcSEcCtD
Diethylpropion—Chest pain—Fluorouracil—urinary bladder cancer	0.00325	0.00325	CcSEcCtD
Diethylpropion—Myalgia—Fluorouracil—urinary bladder cancer	0.00325	0.00325	CcSEcCtD
Diethylpropion—Leukopenia—Cisplatin—urinary bladder cancer	0.00324	0.00324	CcSEcCtD
Diethylpropion—Constipation—Thiotepa—urinary bladder cancer	0.00322	0.00322	CcSEcCtD
Diethylpropion—Discomfort—Fluorouracil—urinary bladder cancer	0.00321	0.00321	CcSEcCtD
Diethylpropion—Cerebrovascular accident—Epirubicin—urinary bladder cancer	0.00315	0.00315	CcSEcCtD
Diethylpropion—Convulsion—Cisplatin—urinary bladder cancer	0.00314	0.00314	CcSEcCtD
Diethylpropion—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00311	0.00311	CcSEcCtD
Diethylpropion—Myalgia—Cisplatin—urinary bladder cancer	0.00308	0.00308	CcSEcCtD
Diethylpropion—Ill-defined disorder—Etoposide—urinary bladder cancer	0.00308	0.00308	CcSEcCtD
Diethylpropion—Anxiety—Cisplatin—urinary bladder cancer	0.00307	0.00307	CcSEcCtD
Diethylpropion—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.00306	0.00306	CcSEcCtD
Diethylpropion—Discomfort—Cisplatin—urinary bladder cancer	0.00304	0.00304	CcSEcCtD
Diethylpropion—Tachycardia—Fluorouracil—urinary bladder cancer	0.00304	0.00304	CcSEcCtD
Diethylpropion—Urticaria—Thiotepa—urinary bladder cancer	0.00299	0.00299	CcSEcCtD
Diethylpropion—Malaise—Etoposide—urinary bladder cancer	0.00299	0.00299	CcSEcCtD
Diethylpropion—Leukopenia—Etoposide—urinary bladder cancer	0.00297	0.00297	CcSEcCtD
Diethylpropion—Cerebrovascular accident—Doxorubicin—urinary bladder cancer	0.00291	0.00291	CcSEcCtD
Diethylpropion—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.00289	0.00289	CcSEcCtD
Diethylpropion—Tachycardia—Cisplatin—urinary bladder cancer	0.00288	0.00288	CcSEcCtD
Diethylpropion—Convulsion—Etoposide—urinary bladder cancer	0.00287	0.00287	CcSEcCtD
Diethylpropion—Insomnia—Gemcitabine—urinary bladder cancer	0.00287	0.00287	CcSEcCtD
Diethylpropion—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.00286	0.00286	CcSEcCtD
Diethylpropion—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.00284	0.00284	CcSEcCtD
Diethylpropion—Dyspnoea—Gemcitabine—urinary bladder cancer	0.00283	0.00283	CcSEcCtD
Diethylpropion—Chest pain—Etoposide—urinary bladder cancer	0.00282	0.00282	CcSEcCtD
Diethylpropion—Insomnia—Fluorouracil—urinary bladder cancer	0.00282	0.00282	CcSEcCtD
Diethylpropion—Somnolence—Gemcitabine—urinary bladder cancer	0.00282	0.00282	CcSEcCtD
Diethylpropion—Discomfort—Etoposide—urinary bladder cancer	0.00279	0.00279	CcSEcCtD
Diethylpropion—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00278	0.00278	CcSEcCtD
Diethylpropion—Somnolence—Fluorouracil—urinary bladder cancer	0.00277	0.00277	CcSEcCtD
Diethylpropion—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00274	0.00274	CcSEcCtD
Diethylpropion—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00274	0.00274	CcSEcCtD
Diethylpropion—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.00273	0.00273	CcSEcCtD
Diethylpropion—Constipation—Gemcitabine—urinary bladder cancer	0.00271	0.00271	CcSEcCtD
Diethylpropion—Pancytopenia—Methotrexate—urinary bladder cancer	0.00271	0.00271	CcSEcCtD
Diethylpropion—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.00269	0.00269	CcSEcCtD
Diethylpropion—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00269	0.00269	CcSEcCtD
Diethylpropion—Dysuria—Methotrexate—urinary bladder cancer	0.00267	0.00267	CcSEcCtD
Diethylpropion—Tachycardia—Etoposide—urinary bladder cancer	0.00264	0.00264	CcSEcCtD
Diethylpropion—Dyspnoea—Cisplatin—urinary bladder cancer	0.00263	0.00263	CcSEcCtD
Diethylpropion—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.00263	0.00263	CcSEcCtD
Diethylpropion—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00262	0.00262	CcSEcCtD
Diethylpropion—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00261	0.00261	CcSEcCtD
Diethylpropion—Diarrhoea—Thiotepa—urinary bladder cancer	0.00258	0.00258	CcSEcCtD
Diethylpropion—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00257	0.00257	CcSEcCtD
Diethylpropion—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00255	0.00255	CcSEcCtD
Diethylpropion—Drowsiness—Methotrexate—urinary bladder cancer	0.00254	0.00254	CcSEcCtD
Diethylpropion—Pancytopenia—Epirubicin—urinary bladder cancer	0.00253	0.00253	CcSEcCtD
Diethylpropion—Dysuria—Epirubicin—urinary bladder cancer	0.00249	0.00249	CcSEcCtD
Diethylpropion—Dizziness—Thiotepa—urinary bladder cancer	0.00249	0.00249	CcSEcCtD
Diethylpropion—Urticaria—Fluorouracil—urinary bladder cancer	0.00248	0.00248	CcSEcCtD
Diethylpropion—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00243	0.00243	CcSEcCtD
Diethylpropion—Dyspnoea—Etoposide—urinary bladder cancer	0.00241	0.00241	CcSEcCtD
Diethylpropion—Somnolence—Etoposide—urinary bladder cancer	0.00241	0.00241	CcSEcCtD
Diethylpropion—Vomiting—Thiotepa—urinary bladder cancer	0.0024	0.0024	CcSEcCtD
Diethylpropion—Drowsiness—Epirubicin—urinary bladder cancer	0.00238	0.00238	CcSEcCtD
Diethylpropion—Rash—Thiotepa—urinary bladder cancer	0.00238	0.00238	CcSEcCtD
Diethylpropion—Dermatitis—Thiotepa—urinary bladder cancer	0.00237	0.00237	CcSEcCtD
Diethylpropion—Agranulocytosis—Methotrexate—urinary bladder cancer	0.00237	0.00237	CcSEcCtD
Diethylpropion—Headache—Thiotepa—urinary bladder cancer	0.00236	0.00236	CcSEcCtD
Diethylpropion—Pancytopenia—Doxorubicin—urinary bladder cancer	0.00234	0.00234	CcSEcCtD
Diethylpropion—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00234	0.00234	CcSEcCtD
Diethylpropion—Constipation—Etoposide—urinary bladder cancer	0.00231	0.00231	CcSEcCtD
Diethylpropion—Dysuria—Doxorubicin—urinary bladder cancer	0.00231	0.00231	CcSEcCtD
Diethylpropion—Nausea—Thiotepa—urinary bladder cancer	0.00224	0.00224	CcSEcCtD
Diethylpropion—Feeling abnormal—Etoposide—urinary bladder cancer	0.00223	0.00223	CcSEcCtD
Diethylpropion—Agranulocytosis—Epirubicin—urinary bladder cancer	0.00222	0.00222	CcSEcCtD
Diethylpropion—Drowsiness—Doxorubicin—urinary bladder cancer	0.0022	0.0022	CcSEcCtD
Diethylpropion—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00217	0.00217	CcSEcCtD
Diethylpropion—Urticaria—Etoposide—urinary bladder cancer	0.00215	0.00215	CcSEcCtD
Diethylpropion—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00213	0.00213	CcSEcCtD
Diethylpropion—Dizziness—Fluorouracil—urinary bladder cancer	0.00206	0.00206	CcSEcCtD
Diethylpropion—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.00205	0.00205	CcSEcCtD
Diethylpropion—Diarrhoea—Cisplatin—urinary bladder cancer	0.00202	0.00202	CcSEcCtD
Diethylpropion—Alopecia—Methotrexate—urinary bladder cancer	0.00202	0.00202	CcSEcCtD
Diethylpropion—Vomiting—Gemcitabine—urinary bladder cancer	0.00202	0.00202	CcSEcCtD
Diethylpropion—Rash—Gemcitabine—urinary bladder cancer	0.002	0.002	CcSEcCtD
Diethylpropion—Dermatitis—Gemcitabine—urinary bladder cancer	0.002	0.002	CcSEcCtD
Diethylpropion—Erythema—Methotrexate—urinary bladder cancer	0.00199	0.00199	CcSEcCtD
Diethylpropion—Headache—Gemcitabine—urinary bladder cancer	0.00199	0.00199	CcSEcCtD
Diethylpropion—Vomiting—Fluorouracil—urinary bladder cancer	0.00198	0.00198	CcSEcCtD
Diethylpropion—Rash—Fluorouracil—urinary bladder cancer	0.00196	0.00196	CcSEcCtD
Diethylpropion—Dermatitis—Fluorouracil—urinary bladder cancer	0.00196	0.00196	CcSEcCtD
Diethylpropion—Headache—Fluorouracil—urinary bladder cancer	0.00195	0.00195	CcSEcCtD
Diethylpropion—Arrhythmia—Epirubicin—urinary bladder cancer	0.00191	0.00191	CcSEcCtD
Diethylpropion—Alopecia—Epirubicin—urinary bladder cancer	0.00189	0.00189	CcSEcCtD
Diethylpropion—Nausea—Gemcitabine—urinary bladder cancer	0.00188	0.00188	CcSEcCtD
Diethylpropion—Vomiting—Cisplatin—urinary bladder cancer	0.00188	0.00188	CcSEcCtD
Diethylpropion—Vision blurred—Methotrexate—urinary bladder cancer	0.00187	0.00187	CcSEcCtD
Diethylpropion—Rash—Cisplatin—urinary bladder cancer	0.00186	0.00186	CcSEcCtD
Diethylpropion—Dermatitis—Cisplatin—urinary bladder cancer	0.00186	0.00186	CcSEcCtD
Diethylpropion—Erythema—Epirubicin—urinary bladder cancer	0.00186	0.00186	CcSEcCtD
Diethylpropion—Diarrhoea—Etoposide—urinary bladder cancer	0.00185	0.00185	CcSEcCtD
Diethylpropion—Nausea—Fluorouracil—urinary bladder cancer	0.00185	0.00185	CcSEcCtD
Diethylpropion—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.00184	0.00184	CcSEcCtD
Diethylpropion—Tension—Epirubicin—urinary bladder cancer	0.00182	0.00182	CcSEcCtD
Diethylpropion—Nervousness—Epirubicin—urinary bladder cancer	0.00181	0.00181	CcSEcCtD
Diethylpropion—Malaise—Methotrexate—urinary bladder cancer	0.00179	0.00179	CcSEcCtD
Diethylpropion—Dizziness—Etoposide—urinary bladder cancer	0.00179	0.00179	CcSEcCtD
Diethylpropion—Leukopenia—Methotrexate—urinary bladder cancer	0.00178	0.00178	CcSEcCtD
Diethylpropion—Arrhythmia—Doxorubicin—urinary bladder cancer	0.00177	0.00177	CcSEcCtD
Diethylpropion—Nausea—Cisplatin—urinary bladder cancer	0.00175	0.00175	CcSEcCtD
Diethylpropion—Vision blurred—Epirubicin—urinary bladder cancer	0.00175	0.00175	CcSEcCtD
Diethylpropion—Alopecia—Doxorubicin—urinary bladder cancer	0.00175	0.00175	CcSEcCtD
Diethylpropion—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.00172	0.00172	CcSEcCtD
Diethylpropion—Convulsion—Methotrexate—urinary bladder cancer	0.00172	0.00172	CcSEcCtD
Diethylpropion—Vomiting—Etoposide—urinary bladder cancer	0.00172	0.00172	CcSEcCtD
Diethylpropion—Erythema—Doxorubicin—urinary bladder cancer	0.00172	0.00172	CcSEcCtD
Diethylpropion—Agitation—Epirubicin—urinary bladder cancer	0.00171	0.00171	CcSEcCtD
Diethylpropion—Rash—Etoposide—urinary bladder cancer	0.00171	0.00171	CcSEcCtD
Diethylpropion—Dermatitis—Etoposide—urinary bladder cancer	0.0017	0.0017	CcSEcCtD
Diethylpropion—Headache—Etoposide—urinary bladder cancer	0.0017	0.0017	CcSEcCtD
Diethylpropion—Chest pain—Methotrexate—urinary bladder cancer	0.00169	0.00169	CcSEcCtD
Diethylpropion—Myalgia—Methotrexate—urinary bladder cancer	0.00169	0.00169	CcSEcCtD
Diethylpropion—Tension—Doxorubicin—urinary bladder cancer	0.00169	0.00169	CcSEcCtD
Diethylpropion—Malaise—Epirubicin—urinary bladder cancer	0.00168	0.00168	CcSEcCtD
Diethylpropion—Discomfort—Methotrexate—urinary bladder cancer	0.00167	0.00167	CcSEcCtD
Diethylpropion—Nervousness—Doxorubicin—urinary bladder cancer	0.00167	0.00167	CcSEcCtD
Diethylpropion—Leukopenia—Epirubicin—urinary bladder cancer	0.00166	0.00166	CcSEcCtD
Diethylpropion—Palpitations—Epirubicin—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Diethylpropion—Vision blurred—Doxorubicin—urinary bladder cancer	0.00162	0.00162	CcSEcCtD
Diethylpropion—Convulsion—Epirubicin—urinary bladder cancer	0.00161	0.00161	CcSEcCtD
Diethylpropion—Nausea—Etoposide—urinary bladder cancer	0.00161	0.00161	CcSEcCtD
Diethylpropion—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.0016	0.0016	CcSEcCtD
Diethylpropion—Chest pain—Epirubicin—urinary bladder cancer	0.00158	0.00158	CcSEcCtD
Diethylpropion—Myalgia—Epirubicin—urinary bladder cancer	0.00158	0.00158	CcSEcCtD
Diethylpropion—Agitation—Doxorubicin—urinary bladder cancer	0.00158	0.00158	CcSEcCtD
Diethylpropion—Anxiety—Epirubicin—urinary bladder cancer	0.00158	0.00158	CcSEcCtD
Diethylpropion—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Diethylpropion—Discomfort—Epirubicin—urinary bladder cancer	0.00156	0.00156	CcSEcCtD
Diethylpropion—Malaise—Doxorubicin—urinary bladder cancer	0.00155	0.00155	CcSEcCtD
Diethylpropion—Dry mouth—Epirubicin—urinary bladder cancer	0.00155	0.00155	CcSEcCtD
Diethylpropion—Leukopenia—Doxorubicin—urinary bladder cancer	0.00154	0.00154	CcSEcCtD
Diethylpropion—Palpitations—Doxorubicin—urinary bladder cancer	0.00152	0.00152	CcSEcCtD
Diethylpropion—Convulsion—Doxorubicin—urinary bladder cancer	0.00149	0.00149	CcSEcCtD
Diethylpropion—Tachycardia—Epirubicin—urinary bladder cancer	0.00148	0.00148	CcSEcCtD
Diethylpropion—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.00148	0.00148	CcSEcCtD
Diethylpropion—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.00147	0.00147	CcSEcCtD
Diethylpropion—Insomnia—Methotrexate—urinary bladder cancer	0.00147	0.00147	CcSEcCtD
Diethylpropion—Myalgia—Doxorubicin—urinary bladder cancer	0.00146	0.00146	CcSEcCtD
Diethylpropion—Chest pain—Doxorubicin—urinary bladder cancer	0.00146	0.00146	CcSEcCtD
Diethylpropion—Anxiety—Doxorubicin—urinary bladder cancer	0.00146	0.00146	CcSEcCtD
Diethylpropion—Discomfort—Doxorubicin—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Diethylpropion—Dyspnoea—Methotrexate—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Diethylpropion—Somnolence—Methotrexate—urinary bladder cancer	0.00144	0.00144	CcSEcCtD
Diethylpropion—Dry mouth—Doxorubicin—urinary bladder cancer	0.00143	0.00143	CcSEcCtD
Diethylpropion—Dyspepsia—Methotrexate—urinary bladder cancer	0.00143	0.00143	CcSEcCtD
Diethylpropion—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.0014	0.0014	CcSEcCtD
Diethylpropion—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.00138	0.00138	CcSEcCtD
Diethylpropion—Insomnia—Epirubicin—urinary bladder cancer	0.00137	0.00137	CcSEcCtD
Diethylpropion—Tachycardia—Doxorubicin—urinary bladder cancer	0.00137	0.00137	CcSEcCtD
Diethylpropion—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.00136	0.00136	CcSEcCtD
Diethylpropion—Dyspnoea—Epirubicin—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Diethylpropion—Somnolence—Epirubicin—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Diethylpropion—Feeling abnormal—Methotrexate—urinary bladder cancer	0.00134	0.00134	CcSEcCtD
Diethylpropion—Dyspepsia—Epirubicin—urinary bladder cancer	0.00134	0.00134	CcSEcCtD
Diethylpropion—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.00131	0.00131	CcSEcCtD
Diethylpropion—Constipation—Epirubicin—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Diethylpropion—Urticaria—Methotrexate—urinary bladder cancer	0.00129	0.00129	CcSEcCtD
Diethylpropion—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Diethylpropion—Insomnia—Doxorubicin—urinary bladder cancer	0.00127	0.00127	CcSEcCtD
Diethylpropion—Dyspnoea—Doxorubicin—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Diethylpropion—Feeling abnormal—Epirubicin—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Diethylpropion—Somnolence—Doxorubicin—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Diethylpropion—Dyspepsia—Doxorubicin—urinary bladder cancer	0.00124	0.00124	CcSEcCtD
Diethylpropion—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Diethylpropion—Urticaria—Epirubicin—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Diethylpropion—Constipation—Doxorubicin—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Diethylpropion—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.00116	0.00116	CcSEcCtD
Diethylpropion—Urticaria—Doxorubicin—urinary bladder cancer	0.00112	0.00112	CcSEcCtD
Diethylpropion—Diarrhoea—Methotrexate—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Diethylpropion—Dizziness—Methotrexate—urinary bladder cancer	0.00107	0.00107	CcSEcCtD
Diethylpropion—Diarrhoea—Epirubicin—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Diethylpropion—Vomiting—Methotrexate—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Diethylpropion—Rash—Methotrexate—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Diethylpropion—Dermatitis—Methotrexate—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Diethylpropion—Headache—Methotrexate—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Diethylpropion—Dizziness—Epirubicin—urinary bladder cancer	0.001	0.001	CcSEcCtD
Diethylpropion—Vomiting—Epirubicin—urinary bladder cancer	0.000965	0.000965	CcSEcCtD
Diethylpropion—Nausea—Methotrexate—urinary bladder cancer	0.000963	0.000963	CcSEcCtD
Diethylpropion—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000961	0.000961	CcSEcCtD
Diethylpropion—Rash—Epirubicin—urinary bladder cancer	0.000957	0.000957	CcSEcCtD
Diethylpropion—Dermatitis—Epirubicin—urinary bladder cancer	0.000956	0.000956	CcSEcCtD
Diethylpropion—Headache—Epirubicin—urinary bladder cancer	0.00095	0.00095	CcSEcCtD
Diethylpropion—Dizziness—Doxorubicin—urinary bladder cancer	0.000928	0.000928	CcSEcCtD
Diethylpropion—Nausea—Epirubicin—urinary bladder cancer	0.000901	0.000901	CcSEcCtD
Diethylpropion—Vomiting—Doxorubicin—urinary bladder cancer	0.000893	0.000893	CcSEcCtD
Diethylpropion—Rash—Doxorubicin—urinary bladder cancer	0.000885	0.000885	CcSEcCtD
Diethylpropion—Dermatitis—Doxorubicin—urinary bladder cancer	0.000884	0.000884	CcSEcCtD
Diethylpropion—Headache—Doxorubicin—urinary bladder cancer	0.000879	0.000879	CcSEcCtD
Diethylpropion—Nausea—Doxorubicin—urinary bladder cancer	0.000834	0.000834	CcSEcCtD
